Odyssey Therapeutics, Inc. · NASDAQ:ODTX
Lightspeed Venture Partners XV-B (Ignite), L.P. reported a 7.60% stake in Odyssey Therapeutics, Inc. (Schedule 13G)
Event May 11, 2026 · Filed May 18, 2026
Lightspeed Venture Partners XV-B (Ignite), L.P. reported a 7.60% stake in Odyssey Therapeutics, Inc., 3,608,443 shares, as a passive investor on May 11, 2026. Filed May 18, 2026 (Schedule 13G).
- Stake
- 7.60%
- Shares
- 3,608,443
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Lightspeed Venture Partners XV-B (Ignite), L.P. | 7.60% | 3,608,443 |
| Lightspeed General Partner XV-B (Ignite), L.P. | 7.60% | 3,608,443 |
| Lightspeed Ultimate General Partner XV-B (Ignite), L.L.C. | 7.60% | 3,608,443 |
Source
Related
- Odyssey Therapeutics, Inc.
- Lightspeed Venture Partners XV-B (Ignite), L.P.
- Odyssey Therapeutics, Inc. shareholders
- Schedule 13G · FMR LLC · Jun 5, 2026
- Schedule 13D · SR One Capital Management, LLC · May 18, 2026
- Schedule 13D · Tpg Gp A, LLC · May 18, 2026
- Schedule 13D · Jeito II S.L.P. · May 15, 2026
- Schedule 13D · Dimension Capital II, L.P. · May 15, 2026